Trial Profile
Open Label Study to Assess the Efficacy, Safety and Dosing of Clevidipine in Pediatric Patients Undergoing Surgery
Status:
Suspended
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2023
Price :
$35
*
At a glance
- Drugs Clevidipine (Primary)
- Indications Perioperative hypertension
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Acronyms PIONEER
- Sponsors Chiesi Farmaceutici; Chiesi USA
- 14 Feb 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2024.
- 14 Feb 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2024.
- 03 Jun 2021 Planned End Date changed from 1 Dec 2018 to 1 Dec 2022.